Literature DB >> 28360149

NOTCH1 mutation, TP53 alteration and myeloid antigen expression predict outcome heterogeneity in children with first relapse of T-cell acute lymphoblastic leukemia.

Jana Hof1,2, Corinne Kox3,4,5, Stefanie Groeneveld-Krentz1, Obul R Bandapalli3,4, Leonid Karawajew1, Katharina Schedel1, Joachim B Kunz3,4, Cornelia Eckert1,2, Wolf-Dieter Ludwig6, Richard Ratei6, Peter Rhein1, Günter Henze1, Martina U Muckenthaler3,4, Andreas E Kulozik3,4, Arend von Stackelberg1, Renate Kirschner-Schwabe7,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28360149      PMCID： PMC5566048          DOI： 10.3324/haematol.2016.157792

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

Authors:  Gesche Tallen; Richard Ratei; Georg Mann; Gertjan Kaspers; Felix Niggli; Alexandr Karachunsky; Wolfram Ebell; Gabriele Escherich; Martin Schrappe; Thomas Klingebiel; Ruediger Fengler; Günter Henze; Arend von Stackelberg
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

2.  Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.

Authors:  Jana Hof; Stefanie Krentz; Claudia van Schewick; Gabriele Körner; Shabnam Shalapour; Peter Rhein; Leonid Karawajew; Wolf-Dieter Ludwig; Karl Seeger; Günter Henze; Arend von Stackelberg; Christian Hagemeier; Cornelia Eckert; Renate Kirschner-Schwabe
Journal:  J Clin Oncol       Date:  2011-07-11       Impact factor: 44.544

3.  Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.

Authors:  M Wada; C R Bartram; H Nakamura; M Hachiya; D L Chen; J Borenstein; C W Miller; L Ludwig; T E Hansen-Hagge; W D Ludwig
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

4.  RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.

Authors:  Valentina Gianfelici; Sabina Chiaretti; Sofie Demeyer; Filomena Di Giacomo; Monica Messina; Roberta La Starza; Nadia Peragine; Francesca Paoloni; Ellen Geerdens; Valentina Pierini; Loredana Elia; Marco Mancini; Maria Stefania De Propris; Valerio Apicella; Gianluca Gaidano; Anna Maria Testi; Antonella Vitale; Marco Vignetti; Cristina Mecucci; Anna Guarini; Jan Cools; Robin Foà
Journal:  Haematologica       Date:  2016-05-05       Impact factor: 9.941

5.  Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.

Authors:  Valentino Conter; Maria Grazia Valsecchi; Barbara Buldini; Rosanna Parasole; Franco Locatelli; Antonella Colombini; Carmelo Rizzari; Maria Caterina Putti; Elena Barisone; Luca Lo Nigro; Nicola Santoro; Ottavio Ziino; Andrea Pession; Anna Maria Testi; Concetta Micalizzi; Fiorina Casale; Paolo Pierani; Simone Cesaro; Monica Cellini; Daniela Silvestri; Giovanni Cazzaniga; Andrea Biondi; Giuseppe Basso
Journal:  Lancet Haematol       Date:  2016-01-26       Impact factor: 18.959

6.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

7.  Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.

Authors:  Nitin Jain; Audrey V Lamb; Susan O'Brien; Farhad Ravandi; Marina Konopleva; Elias Jabbour; Zhuang Zuo; Jeffrey Jorgensen; Pei Lin; Sherry Pierce; Deborah Thomas; Michael Rytting; Gautam Borthakur; Tapan Kadia; Jorge Cortes; Hagop M Kantarjian; Joseph D Khoury
Journal:  Blood       Date:  2016-01-08       Impact factor: 22.113

8.  NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.

Authors:  Obul R Bandapalli; Martin Zimmermann; Corinne Kox; Martin Stanulla; Martin Schrappe; Wolf-Dieter Ludwig; Rolf Koehler; Martina U Muckenthaler; Andreas E Kulozik
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

9.  Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.

Authors:  S Jenkinson; K Koo; M R Mansour; N Goulden; A Vora; C Mitchell; R Wade; S Richards; J Hancock; A V Moorman; D C Linch; R E Gale
Journal:  Leukemia       Date:  2012-07-03       Impact factor: 11.528

10.  The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function.

Authors:  C Kox; M Zimmermann; M Stanulla; S Leible; M Schrappe; W-D Ludwig; R Koehler; G Tolle; O R Bandapalli; S Breit; M U Muckenthaler; A E Kulozik
Journal:  Leukemia       Date:  2010-10-14       Impact factor: 11.528
View more
  3 in total

1.  Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.

Authors:  Jessica I Hoell; Sebastian Ginzel; Michaela Kuhlen; Andreas Kloetgen; Michael Gombert; Ute Fischer; Daniel Hein; Salih Demir; Martin Stanulla; Martin Schrappe; Udo Zur Stadt; Peter Bader; Florian Babor; Friedhelm Schuster; Brigitte Strahm; Julia Alten; Anja Moericke; Gabriele Escherich; Arend von Stackelberg; Ralf Thiele; Alice C McHardy; Christina Peters; Beat Bornhauser; Jean-Pierre Bourquin; Stefan Krause; Juergen Enczmann; Lüder Hinrich Meyer; Cornelia Eckert; Arndt Borkhardt; Roland Meisel
Journal:  Blood Adv       Date:  2019-10-22

2.  Chemotherapy and mismatch repair deficiency cooperate to fuel TP53 mutagenesis and ALL relapse.

Authors:  Fan Yang; Samuel W Brady; Chao Tang; Huiying Sun; Lijuan Du; Malwine J Barz; Xiaotu Ma; Yao Chen; Houshun Fang; Xiaomeng Li; Pandurang Kolekar; Omkar Pathak; Jiaoyang Cai; Lixia Ding; Tianyi Wang; Arend von Stackelberg; Shuhong Shen; Cornelia Eckert; Jeffery M Klco; Hongzhuan Chen; Caiwen Duan; Yu Liu; Hui Li; Benshang Li; Renate Kirschner-Schwabe; Jinghui Zhang; Bin-Bing S Zhou
Journal:  Nat Cancer       Date:  2021-07-22

3.  [The role and research progress of NOTCH1 in T-cell acute lymphoblastic leukemia].

Authors:  S S Guo; J Q Mi; J Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.